EGX:PHAR Revenue

In the year 2024, Egyptian International Pharmaceutical Industries Company had annual revenue of 7.59B EGP with 45.09% growth. Egyptian International Pharmaceutical Industries Company had revenue of 2.14B in the quarter ending December 31, 2024, with 37.92% growth.

Revenue

7.59B

Revenue Growth

+45.09%

P/S Ratio

0.99

Revenue / Employee

n/a

Employees

n/a

Market Cap

7.53B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.59B	2.36B	45.09%
Dec 31, 2023	5.23B	1.28B	32.27%
Dec 31, 2022	3.96B	546.35M	16.03%
Dec 31, 2021	3.41B	523.18M	18.13%
Dec 31, 2020	2.89B	-525.41M	-15.40%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Commercial International Bank Egypt (CIB) S.A.E.	114.75B
El Sewedy Electric Company	231.98B
Talaat Moustafa Group Holding	42.67B
Eastern Company S.A.E	30.98B
Misr Fertilizer Production Company	19.65B
Egypt Aluminum	40.94B
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.)	20.16B
Qatar National Bank	42.70B

Revenue Rankings